These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 3541330

  • 1. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG, Henry M, Ferguson RM.
    Transplantation; 1987 Jan; 43(1):85-90. PubMed ID: 3541330
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sequential antilymphocyte globulin/cyclosporine immunosuppression in cadaveric renal transplantation. Effect of duration of ALG therapy.
    Stratta RJ, D'Alessandro AM, Armbrust MJ, Pirsch JD, Sollinger HW, Kalayoglu M, Belzer FO.
    Transplantation; 1989 Jan; 47(1):96-102. PubMed ID: 2643236
    [Abstract] [Full Text] [Related]

  • 4. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Sutherland DE, Fryd DS, Strand MH, Canafax DM, Ascher NL, Payne WD, Simmons RL, Najarian JS.
    Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
    [Abstract] [Full Text] [Related]

  • 5. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
    Johnson CP, Simmons RL, Sutherland DE, Canafax DM, Ascher NL, Payne WD, Flick B, Najarian JS, Fryd DS.
    Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
    [Abstract] [Full Text] [Related]

  • 6. Effect of cyclosporine and delayed graft function on posttransplantation erythropoiesis.
    Besarab A, Caro J, Jarrell B, Burke J, Francos G, Mallon E, Karsch R.
    Transplantation; 1985 Dec; 40(6):624-31. PubMed ID: 3907033
    [Abstract] [Full Text] [Related]

  • 7. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients.
    Boudreaux JP, McHugh L, Canafax DM, Ascher N, Sutherland DE, Payne W, Simmons RL, Najarian JS, Fryd DS.
    Transplantation; 1987 Sep; 44(3):376-81. PubMed ID: 3307061
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum cyclosporine kinetic profile. Failure to correlate with nephrotoxicity or rejection episodes following sequential immunotherapy for renal transplantation.
    Sommer BG, Sing DE, Henry ML, Ferguson RM, Orosz CG.
    Transplantation; 1988 Jan; 45(1):86-90. PubMed ID: 3276069
    [Abstract] [Full Text] [Related]

  • 11. A comparison of the effects of cyclosporine versus antilymphocyte globulin on delayed graft function in cadaver renal transplant recipients.
    Michael HJ, Francos GC, Burke JF, Besarab A, Moritz M, Gillum D, Jarrell B.
    Transplantation; 1989 Nov; 48(5):805-8. PubMed ID: 2683263
    [Abstract] [Full Text] [Related]

  • 12. Detrimental effect of cyclosporine on initial function of cadaver renal allografts following extended preservation. Results of a randomized prospective study.
    Novick AC, Hwei HH, Steinmuller D, Streem SB, Cunningham RJ, Steinhilber D, Goormastic M, Buszta C.
    Transplantation; 1986 Aug; 42(2):154-8. PubMed ID: 3526655
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antilymphocyte globulin with a small dose of cyclosporine A and prednisone as the induction of immunosuppression in renal allograft recipients.
    Boratyńska M, Szepietowski T, Szewczyk Z, Szydłowski Z.
    Arch Immunol Ther Exp (Warsz); 1992 Aug; 40(2):163-8. PubMed ID: 1299176
    [Abstract] [Full Text] [Related]

  • 17. Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Results of a single institution prospective randomized trial.
    Hanto DW, Jendrisak MD, So SK, McCullough CS, Rush TM, Michalski SM, Phelan D, Mohanakumar T.
    Transplantation; 1994 Feb; 57(3):377-84. PubMed ID: 8108873
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Peri-operative antilymphoblast globulin (ALG) and delayed initiation of cyclosporine (CsA) diminishes the requirement for prolonged dialysis therapy after renal transplantation.
    Nestor ZJ, Rocher LL, Merion RM, Swartz RD, Turcotte JG, Campbell DA.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1556-7. PubMed ID: 2652505
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.